Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
POCI Transcript
Precision Optics Corporation, Inc. (POCI) Q1 2026 Earnings Call Transcript
Positive11-13
The earnings call indicates strong revenue growth, especially in key manufacturing programs, and an optimistic outlook for fiscal 2026 with improved gross margins and positive adjusted EBITDA. The Q&A section did not reveal significant negative trends, and the company's strategic expansion into defense aerospace alongside medical devices suggests diversification and potential profitability. Despite some concerns over gross margins and delayed orders, the overall sentiment is positive, supported by strong revenue expectations and strategic operational investments.
Precision Optics Corporation, Inc. (POCI) Q4 2025 Earnings Call Transcript
Positive9-29
The earnings call reveals record-high quarterly revenue and a significant increase in production revenue, despite a decline in gross margin. The Q&A section confirms conservative but optimistic guidance, with expectations of improved gross margins and a well-prepared pipeline. Management's clear responses and strategic focus on production and engineering projects suggest a positive outlook. The stock price is likely to react positively, with potential gains of 2% to 8% over the next two weeks.
Precision Optics Corporation, Inc. (NASDAQ:POCI) Q3 2025 Earnings Call Transcript
Unknown5-17
The earnings call reflects significant challenges: a steep decline in gross margins, increased net losses, and staffing issues. The Q&A highlighted uncertainties about engineering revenue and production delays, although management expressed optimism about resolving these issues. Despite a $5 million raise to improve financial health, there's no immediate shareholder return plan. The military program's continuity is positive, but overall, the financial performance and lack of clear guidance on key issues suggest a negative sentiment. The market is likely to react negatively, with a potential stock price decrease between -2% and -8%.
Earnings call transcript: Precision Optics Q3 2025 sees significant revenue drop
Unknown5-15
The earnings call reveals a challenging financial situation with declining revenue, gross margin, and increased net loss. Despite a positive backlog and future purchase commitments, the weak financial performance and negative adjusted EBITDA are concerning. The Q&A highlights unresolved issues like tariffs and production delays, although management remains optimistic about future growth. However, the lack of clear guidance on key developments and ongoing expenses further clouds the outlook, suggesting a negative stock price movement in the short term.
POCI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
